Cancer BiologyImmunityPeer-reviewed
Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand…·George Coukos
This study tracks tumor-reactive TIL clonotypes in melanoma patients before and after TIL-ACT to identify factors associated with clinical response.